2024
U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention
Rosenblum H, Gargano J, Cleveland A, Dahl R, Park I, Whitney E, Castilho J, Sackey E, Niccolai L, Brackney M, Debess E, Ehlers S, Bennett N, Kurtz R, Unger E, Markowitz L. U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention. Journal Of Women's Health 2024, 33: 594-603. PMID: 38608239, DOI: 10.1089/jwh.2023.0462.Peer-Reviewed Original ResearchInvasive cervical cancerEvaluate characteristics of womenPopulation-based descriptive studyInvasive cervical cancer diagnosisCervical cancer screeningReduce cervical cancer ratesPopulation-based surveillance sitesCervical cancer ratesIdentified potential barriersNon-white womenAdvent of screeningPotential barriersCharacteristics of womenIncident invasive cervical cancerCancer screeningPreventive careCancer ratesCervical cancerMental illnessSubstance use disordersChi-square testDescriptive frequenciesDescriptive studyMultiple barriersSurveillance sites
2023
Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019
Sheth S, Johnson N, Sullivan E, Torres A, Oliveira C, Niccolai L. Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019. Journal Of Women's Health 2023, 33: 28-32. PMID: 37943625, PMCID: PMC10794823, DOI: 10.1089/jwh.2022.0456.Peer-Reviewed Original ResearchConceptsMid-adult womenVaccination statusHPV vaccinationHPV vaccineHuman Papillomavirus Vaccination StatusHPV vaccination statusHuman papillomavirus vaccinationAge 26 yearsHealth care providersCross-sectional surveyPapillomavirus vaccinationUnvaccinated womenVaccinated womenVaccine informationCare providersVaccinationAdult womenVaccineWomenBehavioral correlatesCorrelatesStatusPotential benefitsYearsParticipantsHuman papillomavirus vaccine effectiveness by age at vaccination: A systematic review
Ellingson M, Sheikha H, Nyhan K, Oliveira C, Niccolai L. Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review. Human Vaccines & Immunotherapeutics 2023, 19: 2239085. PMID: 37529935, PMCID: PMC10399474, DOI: 10.1080/21645515.2023.2239085.Peer-Reviewed Original ResearchConceptsVaccine effectivenessSystematic reviewHuman Papillomavirus Vaccine EffectivenessVaccine-type HPV infectionYounger ageHigh vaccine effectivenessHuman papillomavirus vaccineVaccine effectiveness studiesYounger age groupsAdolescents ages 15Adolescents ages 9HPV infectionHPV vaccineVaccine initiationPapillomavirus vaccineTime vaccinationAnogenital wartsCervical abnormalitiesCervical cancerDisease outcomeAge groupsOlder ageEffectiveness studiesAge 15AgeAcceptability of 4-poster deer treatment devices for community-wide tick control among residents of high Lyme disease incidence counties in Connecticut and New York, USA
Nawrocki C, Piedmonte N, Niesobecki S, Rowe A, Hansen A, Kaufman A, Foster E, Meek J, Niccolai L, White J, Backenson B, Eisen L, Hook S, Connally N, Hornbostel V, Hinckley A. Acceptability of 4-poster deer treatment devices for community-wide tick control among residents of high Lyme disease incidence counties in Connecticut and New York, USA. Ticks And Tick-borne Diseases 2023, 14: 102231. PMID: 37531890, PMCID: PMC10883357, DOI: 10.1016/j.ttbdis.2023.102231.Peer-Reviewed Original ResearchFailure to Complete Multidose Vaccine Series in Early Childhood.
Michels S, Niccolai L, Hadler J, Freeman R, Albers A, Glanz J, Daley M, Newcomer S. Failure to Complete Multidose Vaccine Series in Early Childhood. Pediatrics 2023, 152 PMID: 37489285, PMCID: PMC10389773, DOI: 10.1542/peds.2022-059844.Peer-Reviewed Original ResearchConceptsVaccine seriesVaccination patternsUS childrenAdditional vaccine doseEarly childhood immunizationVaccine dosePreventable diseaseChildhood immunizationSeries completionNumber of childrenSociodemographic factorsInsurance coverageStrong associationOptimal protectionEarly childhoodBinomial regressionChildrenDosesAssociationStructural barriersCoverage goalsVaccinationImmunizationA review of data systems for assessing the impact of HPV vaccination in selected high-income countries
Wang W, Kothari S, Khoury H, Niccolai L, Garland S, Sundström K, de Pouvourville G, Bonanni P, Chen Y, Franco E. A review of data systems for assessing the impact of HPV vaccination in selected high-income countries. Expert Review Of Vaccines 2023, 22: 161-179. PMID: 36576068, DOI: 10.1080/14760584.2023.2162505.Peer-Reviewed Original ResearchConceptsHigh-income countriesHPV vaccinationCervical cancer prevention policyCharacteristics of HPVHuman papillomavirus vaccinationCervical screening programmeEarly detection measuresCancer prevention policiesWorld Health OrganizationPapillomavirus vaccinationCervical cancerVaccination coverageDisease outcomeScreening programElimination effortsGlobal eliminationPrevention programsTreatment programData SystemVaccinationHealth OrganizationHPVTargeted reviewPrevention policiesUnited StatesClinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review
King L, Lewnard J, Niccolai L. Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review. Open Forum Infectious Diseases 2023, 10: ofad004. PMID: 36726535, PMCID: PMC9887268, DOI: 10.1093/ofid/ofad004.Peer-Reviewed Original ResearchHPV vaccinationHuman papillomavirusNarrative reviewHPV natural historyRecurrent respiratory papillomatosisPublic health considerationsRespiratory papillomatosisOropharyngeal cancerAnogenital wartsPrevious infectionCancer casesUS guidelinesVaccinationImportant causeNatural historyAvailable evidenceSexual behaviorPatientsHealth considerationsCancerCliniciansBroad implementationGreater awarenessWide variationPapillomatosis
2022
Computable Clinical Phenotyping of Postacute Sequelae of COVID-19 in Pediatrics Using Real-World Data
Fashina T, Miller C, Paintsil E, Niccolai L, Brandt C, Oliveira C. Computable Clinical Phenotyping of Postacute Sequelae of COVID-19 in Pediatrics Using Real-World Data. Journal Of The Pediatric Infectious Diseases Society 2022, 12: 113-116. PMID: 36548966, PMCID: PMC9969330, DOI: 10.1093/jpids/piac132.Peer-Reviewed Original ResearchMessaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review
Niccolai L, Johnson N, Torres A, Sullivan E, Hansen C. Messaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review. Journal Of Adolescent Health 2022, 72: 334-343. PMID: 36529616, DOI: 10.1016/j.jadohealth.2022.10.018.Peer-Reviewed Original Research
2021
“The Squeaky Wheel Gets the Grease”: Rental Assistance Applicants’ Quests for a Rationed and Scarce Resource
Keene D, Rosenberg A, Schlesinger P, Whittaker S, Niccolai L, Blankenship K. “The Squeaky Wheel Gets the Grease”: Rental Assistance Applicants’ Quests for a Rationed and Scarce Resource. Social Problems 2021, 70: 203-218. PMID: 36798516, PMCID: PMC9928171, DOI: 10.1093/socpro/spab035.Peer-Reviewed Original Research
2020
A Multi Region Analysis of Shale Drilling Activity and Rates of Sexually Transmitted Infections in the United States
Johnson N, Warren J, Elliott E, Niccolai L, Deziel N. A Multi Region Analysis of Shale Drilling Activity and Rates of Sexually Transmitted Infections in the United States. ISEE Conference Abstracts 2020, 2020 DOI: 10.1289/isee.2020.virtual.p-1089.Peer-Reviewed Original ResearchPhysician and patient prediction of adherence to antiretroviral therapy in HIV positive people in Saint-Petersburg, Russia
Vetrova M, Aleksandrova O, Paschenko A, Toropov S, Rassokhin V, Abyshev R, Levina O, Niccolai L, Heimer R. Physician and patient prediction of adherence to antiretroviral therapy in HIV positive people in Saint-Petersburg, Russia. AIDS Care 2020, 33: 473-477. PMID: 32148065, DOI: 10.1080/09540121.2020.1738005.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyHIV-positive peopleART initiationPositive peopleHIV viral suppressionPatient predictionsAccuracy of providerReview of pharmacyART retentionHIV physiciansViral suppressionPhysicians' predictionsTreatment outcomesART outcomesPatientsAdherenceLaboratory dataTherapyLongitudinal analysisOutcomesProvidersInitiationPhysiciansCare
2019
Introduction to Immunology, Epidemiology, and Immunoepidemiology
Niccolai L, Ruddle N, Krause P. Introduction to Immunology, Epidemiology, and Immunoepidemiology. 2019, 3-17. DOI: 10.1007/978-3-030-25553-4_1.ChaptersIndividual multicellular organismsImmune responseMulticellular organismsRelevant health problemHealth-related eventsInflammatory diseasesSelect populationCombination of cellsHealth problemsEpidemiologic toolImmunoepidemiologyMicrobial infectionsEpidemiologyGenetic polymorphismsImmunologyEnvironmental factorsPopulationAutoimmunityMalignancyOrganismsInfectionDiversityDiseaseStudy962. Trends in Cervical Pre-cancers by Race and Ethnicity During the Human Papillomavirus Vaccine Era, HPV Vaccine Impact Monitoring Project (HPV-IMPACT), United States, 2008–2016
Gargano J, Lewis R, Hunt H, McClung N, Bennett N, Griffin M, Niccolai L, Park I, Powell M, Brackney M, Scahill M, Pemmaraju M, Fink D, Ehlers S, Cleveland A, Unger E, Markowitz L. 962. Trends in Cervical Pre-cancers by Race and Ethnicity During the Human Papillomavirus Vaccine Era, HPV Vaccine Impact Monitoring Project (HPV-IMPACT), United States, 2008–2016. Open Forum Infectious Diseases 2019, 6: s29-s29. PMCID: PMC6809029, DOI: 10.1093/ofid/ofz359.064.Peer-Reviewed Original ResearchAverage annual percentage changeCervical intraepithelial neoplasiaRace/ethnicityVaccine eraYear oldsNH blacksNH whitesHuman papillomavirus vaccine introductionActive population-based surveillanceHPV vaccine eraPopulation-based surveillanceConfidence intervalsAnnual percentage changeSignificant declineScreened womenVaccine impactRace/ethnicity dataCervical cancerIntraepithelial neoplasiaVaccine introductionCIN2Hispanic womenJoinpoint softwareSitu casesAge groupsP836 Trends in anogenital warts since introduction of human papillomavirus vaccines in connecticut, USA
Niccolai L, Brackney M. P836 Trends in anogenital warts since introduction of human papillomavirus vaccines in connecticut, USA. Sexually Transmitted Infections 2019, 95: a351. DOI: 10.1136/sextrans-2019-sti.881.Peer-Reviewed Original ResearchO17.5 Declining trends in anogenital warts since HPV vaccine introduction in a large urban health system, 2013–2017
Yakely A, Oliviera C, Niccolai L. O17.5 Declining trends in anogenital warts since HPV vaccine introduction in a large urban health system, 2013–2017. Sexually Transmitted Infections 2019, 95: a79. DOI: 10.1136/sextrans-2019-sti.203.Peer-Reviewed Original ResearchIncident anogenital wartsAnogenital wartsHPV vaccineVaccine impactBirth cohortImportant public health priorityLarge urban health systemElectronic medical record dataHPV vaccine impactTrends of HPVHPV vaccine introductionNumber of patientsPublic health priorityMedical record dataSignificant declineProportion of visitsUrban health systemBirth cohort analysisCochran-Armitage testEarlier birth cohortsLater birth cohortsMale vaccinationGenital wartsRoutine vaccinationRoutine recommendation
2018
2465. A Pilot Program to Improve Human Papillomavirus Vaccination Status of Adolescents at a School-Based Health Center
Hansen C, North A, Moriarty-Daley A, Niccolai L. 2465. A Pilot Program to Improve Human Papillomavirus Vaccination Status of Adolescents at a School-Based Health Center. Open Forum Infectious Diseases 2018, 5: s739-s739. PMCID: PMC6254943, DOI: 10.1093/ofid/ofy210.2118.Peer-Reviewed Original ResearchSchool-based health centersPrimary care centersHPV vaccine uptakeHPV vaccineHPV vaccinationVaccination statusVaccine uptakeElectronic health recordsEligible patientsImmunization statusHealth centersHuman papillomavirus vaccine uptakeHuman Papillomavirus Vaccination StatusCommon electronic health recordHPV immunization statusHPV vaccine receiptHPV vaccination statusPilot programVaccine receiptCare centerVaccination servicesClinic staffImmunization recordsPatientsVaccinationShale Gas Activity and Increased Rates of Sexually Transmitted Infections in Ohio, 2000-2016
Deziel N, Humeau Z, Elliott E, Warren J, Niccolai L. Shale Gas Activity and Increased Rates of Sexually Transmitted Infections in Ohio, 2000-2016. ISEE Conference Abstracts 2018, 2018 DOI: 10.1289/isesisee.2018.p03.2210.Peer-Reviewed Original ResearchEarly stages of HIV treatment cascade in people living with HIV in Saint-Petersburg, Russia
Vetrova M, Aleksandrova O, Paschenko A, Toropov S, Rassokhin V, Abyshev R, Levina O, Niccolai L, Heimer R. Early stages of HIV treatment cascade in people living with HIV in Saint-Petersburg, Russia. AIDS Care 2018, 30: 857-862. PMID: 29325435, DOI: 10.1080/09540121.2017.1417536.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyUndetectable VLART outcomesInitiation of ARTPilot studyProportion of PLWHMedical chart reviewHIV epidemic controlSuccessful treatment outcomeProportion of peopleChart reviewHIV treatmentDrug abuse statusDisease progressionTreatment outcomesOlder ageTreatment effectivenessART effectivenessEpidemic controlPLWHIllicit drugsHIVSignificant differencesAbuse statusOutcomes
2017
Cervical Adenocarcinoma in Situ in the United States: Results from Population-based Laboratory Surveillance, 2008–2014
Cleveland A, Johnson M, Gargano J, Park I, Griffin M, Niccolai L, Schafer S, Bennett N, Markowitz L, Unger E. Cervical Adenocarcinoma in Situ in the United States: Results from Population-based Laboratory Surveillance, 2008–2014. Open Forum Infectious Diseases 2017, 4: s68-s69. PMCID: PMC5632134, DOI: 10.1093/ofid/ofx162.164.Peer-Reviewed Original ResearchNon-vaccine typesHPV typesCervical cancer screening methodsHPV typing resultsL1 consensus PCRHuman papillomavirus vaccinationPopulation-based surveillanceCancer screening methodsChi-square testCIN3 casesPapillomavirus vaccinationHPV typingMedian ageHPV-18Primary preventionCervical adenocarcinomaVaccine preventionPrecursor lesionsAIS casesCIN3Positive specimensHR typesCIN2Disease controlCell precursors